Sharechat Logo

Blis Technologies upgrades revenues & earnings guidance

Monday 16th March 2020

Text too small?

Blis Technologies (NZX: BLT ) announced today that it has upgraded its revenue and earnings guidance for the financial year ended 31 March 2020. Guidance provided in February was for revenue in excess of $9.4m and EBITDA in excess of $1.0m. The company expects full year revenue of around $10.0m and EBITDA of between $1.5m to $1.7m, subject to completion of existing orders and audit.

Sharp increases in sales of our BLISTM finished goods are complementing a strong year of sales of our branded ingredients into international markets. Additionally, a portion of scheduled project expenditure has been deferred to next financial year due to delays caused by the impacts of COVID-19.

Brian Watson, CEO said, “Sales of our BLIS probiotic brands through pharmacies and online channels in February and March were better than expected. This increase is across the Blis range but is particularly evident for our products with an immune boosting proposition. BLIS TravelProtectTM, UltraBLISTM, DailyDefenceTM and ThroatGuard PROTM have all seen a lift in sales over this period.”

“We have noted media reports of immunity products seeing a lift in demand globally and it appears some of our current increased sales are related to COVID-19 concerns. We believe consumers are looking for products that may help support natural immunity.” “To date our supply chain, from ingredient supply through to manufacture of finished product has been able to meet the lift in demand and we have significantly increased our production to meet anticipated forward orders. We continue to monitor our supply chain for any future constraints.”

Results for the 12 months to 31 March 2020 are expected to be announced in late May.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Scott Technology Trading Update; Rising to the COVID Challenge
New non-binding indicative offer received from apvg, shareholder meeting deferred
U.S. Added 4.8 Million Jobs in June as Reopened Businesses Rehired
Auditors have a duty to be alert to fraud
Strong sales recovery but uncertainty remains over economic outlook and potential second wave of COVID-19
Auditors keep falling into the same trap
The great interruption continues
Update on Clutha Upper Waitaki Lines Project
Napier Port Welcomes Inland Port Funding
Auckland Airport provides details of Other Significant Items expected to impact 2020 financial results and an update on further organisational change

IRG See IRG research reports